Glenmark’s European strategy takes a big leap with Tavulus launch in Spain

INDIA – Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, today announced the launch of Tavulus, a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) in Spain for the treatment of chronic obstructive pulmonary disease (COPD). COPD is a long-term condition that causes lung inflammation, lung tissue damage, and airway narrowing, all of which make breathing difficult. Studies show that nearly 2.5 million people in Spain suffer from COPD. Glenmark will sell the powder under the brand name Tavulus. Tavulus is expected to help a large number of…

Read More

WHO urges China to be more cooperative as its probes to identify COVID-19 origin

WORLD – World Health Organization (WHO) is planning to rollout its next investigation phase to probe the origin of COVID-19 and it has urged China to be more cooperative during this next phase in reference to providing more raw data. The WHO chief, Tedros, said that the organization is laying the groundwork for moving forward with fresh investigations into where Covid-19 came from following a previous attempt that saw WHO send a team of international experts who expressed lack of data as a hinderance into the investigation. Tedros also added…

Read More